First-line oral antidiabetic biguanide tablets for glycemic control and insulin sensitivity in Type 2 Diabetes.
Metformin Hydrochloride tablets produced with specialized hydrophilic matrix polymer technology for continuous steady release. Decreases hepatic glucose production and enhances peripheral glucose uptake with documented cardiovascular safety.
| Active Ingredient | Metformin Hydrochloride 500mg / 1000mg |
| Release Profile | Extended Release (ER) / Immediate (IR) |
| Assay | 98.5% - 101.5% |
Direct from factory/farm prices. Response guaranteed within 24 hours.
Other items in Pharmaceutical Drugs you might be interested in.